Roche CEO laments Swiss franc strength as drugmaker doubles down on U.S. investment
Currency effects weighed on the Swiss drugmaker's first-quarter earnings
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.